Abstract
BackgroundOne of the most relevant pharmacokinetic (PK) parameters for antibody-based therapy in the clinics is receptor occupancy (RO). Each specific therapeutics usually requires a tailored RO assay, an PD-1 RO...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have